This content is in French.
Ibudilast in multiple sclerosis
7 février 2024
Ibudilast, which targets IL-1beta, TNF-alpha and IL-6, has shown beneficial effects on various imaging findings in progressive multiple sclerosis. In this Phase II clinical trial…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Kunio Nakamura et al. Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis. Mult Scler. 2024 Jan 29:13524585231224702.
View the source
